Edition:
United States

Takeda Pharmaceutical Co Ltd (4502.T)

4502.T on Tokyo Stock Exchange

4,696JPY
9 Dec 2016
Change (% chg)

¥121 (+2.64%)
Prev Close
¥4,575
Open
¥4,590
Day's High
¥4,711
Day's Low
¥4,580
Volume
4,538,300
Avg. Vol
2,243,299
52-wk High
¥6,158
52-wk Low
¥4,098

4502.T

Chart for 4502.T

About

Takeda Pharmaceutical Company Limited is a Japan-based company engaged in the pharmaceutical business. The Ethical Pharmaceutical segment is engaged in the manufacture and sale of pharmaceutical products, such as therapeutic substances for diabetes, circulatory drugs, anticancer drugs, drugs for central neurological diseases,... (more)

Overall

Beta: 0.72
Market Cap(Mil.): ¥3,711,704.00
Shares Outstanding(Mil.): 790.40
Dividend: 90.00
Yield (%): 3.83

Financials

  4502.T Industry Sector
P/E (TTM): 24.63 29.73 30.40
EPS (TTM): 190.64 -- --
ROI: 5.02 15.87 15.24
ROE: 7.62 16.99 16.58

BRIEF-Takeda Pharmaceutical to invest more than 100 mln euros in German dengue vaccine plant

* Says will invest more than 100 million euros in dengue vaccine manufacturing plant in Germany Source text for Eikon: Further company coverage:

Nov 29 2016

Deals of the day-Mergers and acquisitions

Nov 2 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:

Nov 02 2016

Fujifilm close to deal to buy Takeda research reagent unit: Nikkei

Japan's Fujifilm Holdings Corp is in final talks to buy Takeda Pharmaceutical Co's 70 percent stake in Wako Pure Chemical Industries for about 200 billion yen ($1.94 billion), the Nikkei business daily reported on Wednesday.

Nov 02 2016

Fujifilm close to deal to buy Takeda research reagent unit-Nikkei

Nov 2 Japan's Fujifilm Holdings Corp is in final talks to buy Takeda Pharmaceutical Co's 70 percent stake in Wako Pure Chemical Industries for about 200 billion yen ($1.94 billion), the Nikkei business daily reported on Wednesday.

Nov 02 2016

BRIEF-Fujifilm close to buying Takeda Research Reagent unit - Nikkei

* Fujifilm close to buying Takeda Research Reagent unit - Nikkei

Nov 02 2016

Japan's Takeda shares halted on news of interest in Valeant assets

TOKYO Trading in shares of Japan's Takeda Pharmaceutical Co was suspended in Tokyo on Wednesday after news the company was interested in buying Canadian drugmaker Valeant Pharmaceutical International Inc's stomach-drug business.

Nov 02 2016

RPT-Valeant in talks to sell Salix stomach business -sources

Nov 1 Valeant Pharmaceuticals International Inc is in talks to sell its Salix stomach business to Japanese pharmaceutical company Takeda Pharamceutical Co Ltd , according to people familiar with the matter.

Nov 01 2016

BRIEF-Mersana announces FDA clearance of IND application for lead antibody-drug conjugate XMT-1522

* Mersana announces FDA clearance of IND application for lead antibody-drug conjugate XMT-1522

Oct 24 2016

BRIEF-Crescendo Biologics, Takeda enter collaboration for Humabody-based therapeutics worth up to $790 mln

* Crescendo Biologics and Takeda enter collaboration for Humabody-based therapeutics worth up to $790m

Oct 10 2016

BRIEF-Takeda Pharmaceutical to raise up to T$35 mln via private placement

* Says it to issue up to 3,500,000 shares via private placement and to raise up to totally T$35 million

Oct 06 2016

Earnings vs. Estimates